dc.contributor.author |
Kanafani Z.A. |
dc.contributor.author |
Khalife N. |
dc.contributor.author |
Kanj S.S. |
dc.contributor.author |
Araj G.F. |
dc.contributor.author |
Khalifeh M. |
dc.contributor.author |
Sharara A.I. |
dc.contributor.editor |
|
dc.date |
Aug-2005 |
dc.date.accessioned |
2017-10-05T16:07:39Z |
dc.date.available |
2017-10-05T16:07:39Z |
dc.date.issued |
2005 |
dc.identifier |
10.1016/j.jinf.2004.11.007 |
dc.identifier.isbn |
|
dc.identifier.issn |
01634453 |
dc.identifier.uri |
http://hdl.handle.net/10938/19947 |
dc.description.abstract |
Objectives. Antibiotics are frequently administered in acute cholecystitis for preoperative prophylaxis or postoperative treatment. The optimal timing, choice, and duration of antibiotics are unclear. Methods. We conducted a retrospective review of all cases of acute cholecystitis between 1996 and 2001 at the American University of Beirut Medical Centre. A survey among general surgeons was also performed to describe the pattern of antibiotic prescribing in uncomplicated acute cholecystitis. A MEDLINE search for guidelines for antibiotic use in acute cholecystitis was conducted. Results. The number of cases of acute cholecystitis was 79. The mean duration of postoperative antibiotic therapy was 5 days. There was no correlation between the severity of symptoms, gallbladder description, or positive gallbladder culture and the use of antibiotics postoperatively. Sixty five percent of interviewed surgeons would continue antibiotic therapy postoperatively for 3 or more days. Search of the medical literature failed to provide clear guidelines for antibiotic use in acute cholecystitis. Conclusions. The use of antibiotics in patients with acute cholecystitis is erratic and costly. Prospective studies are needed to better study the effectiveness of a short course of antibiotics in uncomplicated cases. The role of gallbladder culture in guiding antibiotic therapy should be defined as routine cultures add to the cost without evident benefit. © 2004 The British Infection Society. Published by Elsevier Ltd. All rights reserved. |
dc.format.extent |
|
dc.format.extent |
Pages: (128-134) |
dc.language |
English |
dc.publisher |
LONDON |
dc.relation.ispartof |
Publication Name: Journal of Infection; Publication Year: 2005; Volume: 51; no. 2; Pages: (128-134); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Antibiotic use in acute cholecystitis: Practice patterns in the absence of evidence-based guidelines |
dc.type |
Article |
dc.contributor.affiliation |
Kanafani, Z.A., Division of Infectious Diseases, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 110 72020 Beirut, Lebanon |
dc.contributor.affiliation |
Khalifé, N., School of Pharmacy, Lebanese American University, Byblos, Lebanon |
dc.contributor.affiliation |
Kanj, S.S., Division of Infectious Diseases, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 110 72020 Beirut, Lebanon |
dc.contributor.affiliation |
Araj, G.F., Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 110 72020 Beirut, Lebanon |
dc.contributor.affiliation |
Khalifeh, M., Department of Surgery, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 110 72020 Beirut, Lebanon |
dc.contributor.affiliation |
Sharara, A.I., Division of Gastroenterology, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 110 72020 Beirut, Lebanon |
dc.contributor.authorAddress |
Sharara, A.I.; Division of Gastroenterology, American University of Beirut Medical Center, P.O. Box 11-0236, Riad El Solh 110 72020 Beirut, Lebanon; email: as08@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Surgery; |
dc.contributor.authorDepartment |
Surgery |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
as08@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Kanafani, ZA |
dc.contributor.authorInitials |
Khalife, N |
dc.contributor.authorInitials |
Kanj, SS |
dc.contributor.authorInitials |
Araj, GF |
dc.contributor.authorInitials |
Khalifeh, M |
dc.contributor.authorInitials |
Sharara, AI |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Sharara, AI (reprint author), Amer Univ Beirut, Med Ctr, Div Gastroenterol, POB 11-0236,Riad El Solh 110, Beirut 72020, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Brismar B, 1986, Acta Chir Scand Suppl, V530, P35; Bjorvatn B, 1984, Scand J Gastroenterol Suppl, V90, P65; CLAESSON B, 1984, ACTA CHIR SCAND, V150, P229; Csendes A, 1996, ARCH SURG-CHICAGO, V131, P389; FRIEDLENDER J, 1988, CHEMOTHERAPY, V34, P30; GRANDE M, 1992, EUR J SURG, V158, P109; GRANT MD, 1992, SURG GYNECOL OBSTET, V174, P347; Groezinger K H, 1987, Chemioterapia, V6, P590; HAVIG O, 1973, SCAND J GASTROENTERO, V8, P55; HORTON JD, 2002, FELDMAN SLEISENGER F, P1065; JARVINEN HJ, 1980, ACTA CHIR SCAND, V146, P427; Kapoor V K, 1994, Indian J Gastroenterol, V13, P49; KASHOLMTENGVE B, 1991, SURG GYNECOL OBSTET, V173, P25; KRAJDEN S, 1993, CAN J SURG, V36, P245; KUNE GA, 1975, MED J AUSTRALIA, V2, P627; Lai PBS, 1998, BRIT J SURG, V85, P764; LANDAU O, 1992, WORLD J SURG, V16, P962; LAU WY, 1990, AUST NZ J SURG, V60, P539, DOI 10.1111-j.1445-2197.1990.tb07422.x; LEWIS RT, 1984, CAN J SURG, V27, P44; LISHCHENKO AN, 1986, KHIRURGIYA, P51; Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097-00000658-199804000-00001; MEIJER WS, 1990, NETH J SURG, V42, P96; MULLER EL, 1987, SURG GYNECOL OBSTET, V165, P285; NIELSEN ML, 1981, SCAND J GASTROENTERO, V16, P937; PATERSONBROWN S, 1987, BRIT J HOSP MED, V37, P546; RICO RC, 1989, REV ESP ENFERM APAR, V76, P465; THOMPSON JE, 1990, ARCH SURG-CHICAGO, V125, P261; WATSON JF, 1969, MIL MED, V134, P416 |
dc.description.citedCount |
15 |
dc.description.citedTotWOSCount |
11 |
dc.description.citedWOSCount |
9 |
dc.format.extentCount |
7 |
dc.identifier.articleNo |
|
dc.identifier.coden |
JINFD |
dc.identifier.pubmedID |
16038763 |
dc.identifier.scopusID |
22144498067 |
dc.identifier.url |
|
dc.publisher.address |
32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
J. Infect. |
dc.relation.ispartOfIssue |
2 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Journal of Infection |
dc.relation.ispartofPubTitleAbbr |
J. Infect. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
51 |
dc.source.ID |
WOS:000231155700007 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Biliary |
dc.subject.otherAuthKeyword |
Gallbladder |
dc.subject.otherAuthKeyword |
Infection |
dc.subject.otherAuthKeyword |
Surgery |
dc.subject.otherAuthKeyword |
Survey |
dc.subject.otherChemCAS |
amoxicillin plus clavulanic acid, 74469-00-4, 79198-29-1 |
dc.subject.otherChemCAS |
ampicillin, 69-52-3, 69-53-4, 7177-48-2, 74083-13-9, 94586-58-0 |
dc.subject.otherChemCAS |
carbapenem, 83200-96-8 |
dc.subject.otherChemCAS |
cephalosporin, 11111-12-9 |
dc.subject.otherChemCAS |
Anti-Bacterial Agents |
dc.subject.otherIndex |
aminoglycoside antibiotic agent |
dc.subject.otherIndex |
amoxicillin plus clavulanic acid |
dc.subject.otherIndex |
ampicillin |
dc.subject.otherIndex |
antibiotic agent |
dc.subject.otherIndex |
carbapenem |
dc.subject.otherIndex |
cephalosporin |
dc.subject.otherIndex |
monobactam |
dc.subject.otherIndex |
piperacillin plus tazobactam |
dc.subject.otherIndex |
polypeptide antibiotic agent |
dc.subject.otherIndex |
quinolone derivative |
dc.subject.otherIndex |
acute cholecystitis |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
aged |
dc.subject.otherIndex |
antibiotic prophylaxis |
dc.subject.otherIndex |
antibiotic sensitivity |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
bacterium culture |
dc.subject.otherIndex |
cholecystectomy |
dc.subject.otherIndex |
correlation analysis |
dc.subject.otherIndex |
cost benefit analysis |
dc.subject.otherIndex |
cost of illness |
dc.subject.otherIndex |
drug cost |
dc.subject.otherIndex |
Enterococcus |
dc.subject.otherIndex |
Escherichia coli |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
gallbladder disease |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
information retrieval |
dc.subject.otherIndex |
interview |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
MEDLINE |
dc.subject.otherIndex |
postoperative care |
dc.subject.otherIndex |
practice guideline |
dc.subject.otherIndex |
preoperative care |
dc.subject.otherIndex |
prescription |
dc.subject.otherIndex |
retrospective study |
dc.subject.otherIndex |
surgeon |
dc.subject.otherIndex |
systematic review |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Aged |
dc.subject.otherIndex |
Aged, 80 and over |
dc.subject.otherIndex |
Anti-Bacterial Agents |
dc.subject.otherIndex |
Cholecystectomy |
dc.subject.otherIndex |
Cholecystitis, Acute |
dc.subject.otherIndex |
Enterococcus |
dc.subject.otherIndex |
Escherichia coli |
dc.subject.otherIndex |
Evidence-Based Medicine |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Lebanon |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Physician's Practice Patterns |
dc.subject.otherIndex |
Practice Guidelines |
dc.subject.otherIndex |
Questionnaires |
dc.subject.otherIndex |
Retrospective Studies |
dc.subject.otherKeywordPlus |
DELAYED LAPAROSCOPIC CHOLECYSTECTOMY |
dc.subject.otherKeywordPlus |
HIGH-RISK PATIENTS |
dc.subject.otherKeywordPlus |
BILIARY-TRACT |
dc.subject.otherKeywordPlus |
RANDOMIZED-TRIAL |
dc.subject.otherKeywordPlus |
PROPHYLAXIS |
dc.subject.otherKeywordPlus |
SURGERY |
dc.subject.otherKeywordPlus |
BILE |
dc.subject.otherKeywordPlus |
GALLBLADDER |
dc.subject.otherKeywordPlus |
INFECTION |
dc.subject.otherKeywordPlus |
CEFAZOLIN |
dc.subject.otherWOS |
Infectious Diseases |